{"resourceType": "EvidenceVariable", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"], "versionId": "5", "lastUpdated": "2025-09-14T18:30:51.295Z"}, "contained": [{"resourceType": "Group", "id": "variable-definition", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"]}, "membership": "conceptual", "characteristic": [{"code": {"text": "defined by CodeableConcept"}, "valueCodeableConcept": {"text": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia"}, "exclude": false, "timing": [{"text": "Pre-dose up to 30 minutes post each glucagon administration"}]}]}], "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-variable-handling-not-specified", "display": "Evidence variable handling not specified"}]}}], "identifier": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}], "text": "FEvIR Object Identifier"}, "system": "https://fevir.net/FOI", "value": "267226", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "NCT03421379-primaryOutcome-0", "assigner": {"display": "Computable Publishing LLC"}}], "title": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia (NCT03421379)", "status": "active", "description": "Percentage of participants who achieved treatment success during the controlled insulin-induced hypoglycemia in participants with type 1 diabetes mellitus (T1DM) and participants with type 2 diabetes mellitus (T2DM).Treatment success is defined as an increase in plasma glucose to greater than or equal to (\u2265) 70 milligrams per deciliter (mg/dL) or an increase of \u226520 mg/dL from plasma glucose nadir, without receiving additional actions to increase the plasma glucose concentration. Nadir is defined as the minimum plasma glucose concentration at the time of or within 10 minutes following glucagon administration.", "definition": {"reference": {"reference": "#variable-definition", "type": "Group"}}, "handling": "extension", "id": "267226", "url": "https://fevir.net/resources/EvidenceVariable/267226", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter"}], "citeAs": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia (NCT03421379) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267226. Revised 2025-09-14. Available at: https://fevir.net/resources/EvidenceVariable/267226. Computable resource at: https://fevir.net/resources/EvidenceVariable/267226#json.", "name": "Percentage_of_Participants_Achieving_Treatment_Success_During_Controlled_Insulin_Induced_Hypoglycemia_NCT03421379"}